Consulta nuestras publicaciones
Recursos
Descubre la contribución de OWL Metabolomics al conocimiento científico en nuestra sección de Recursos. Te invitamos a consultar las publicaciones en las que hemos participado, que ofrecen perspectivas clave sobre diferentes áreas terapéuticas. Nuestra biblioteca está aquí para ayudarle en tus necesidades de investigación. Te invitamos a explorar nuestras contribuciones con los recursos que ponemos a tu disposición. Utiliza los filtros para encontrar información por año de publicación, área terapéutica y/o enfermedad.
Lipidomic signatures from physically frail and robust older adults at hospital admission
GeroScience2022;44(3):1677-88
/ 2022
Área: Aging
Patología: Physical frailty
Área: Aging
Patología: Physical frailty
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
Biochem Pharmacol 2024;230(Pt1):116571
/ 2024
Área: Cardiology / Cardiovascular
Patología: Heart failure with preserved ejection fraction
Área: Cardiology / Cardiovascular
Patología: Heart failure with preserved ejection fraction
Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice.
Life Sciences 2024;359:123226
/ 2024
Área: Cardiology / Cardiovascular & Endocrinology
Patología: Cardiovascular disease and Obesity
Área: Cardiology / Cardiovascular & Endocrinology
Patología: Cardiovascular disease and Obesity
Loss of peroxiredoxin 6 (PRDX6) alters lipid composition and distribution resulting in increased sensitivity to ferroptosis.
Biochem J. 2024 (in press)
/ 2024
Área: Oncology and Gastroenterology / Hepatology
Patología: Ferroptosis
Área: Oncology and Gastroenterology / Hepatology
Patología: Ferroptosis
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis: a multicentre, double-blind,randomised, placebo-controlled, phase 2b trial.
Lancet Gastroenterol Hepatol 2024;9(12):1090-100
/ 2024
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.
Gut 2024 (in press)
/ 2024
Área: Rare Disease
Patología: Acute intermittent porphyria
Área: Rare Disease
Patología: Acute intermittent porphyria
Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.
Int J Mol Sci. 2022;23(23):14940
/ 2022
Área: Rare Disease
Patología: Infant Citrullinemia Type 1
Área: Rare Disease
Patología: Infant Citrullinemia Type 1
Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans.
Cardiovasc Res. 2024;120(7):708-22.
/ 2024
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
NAFLD and type 2 diabetes: A practical guide for the joint management.
Gastroenterol Hepatol. 2023;46(10):815-25.
/ 2023
Área: Gastroenterology / Hepatology & Endocrinology
Patología: MASLD/MASH and T2DM
Área: Gastroenterology / Hepatology & Endocrinology
Patología: MASLD/MASH and T2DM
Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue
Biochem Pharmacol 2024;223:116157
/ 2024
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
Área: Cardiology / Cardiovascular
Patología: Cardiovascular disease
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Nat Metab 2024; 6(6):1178-96
/ 2024
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
Contemp Clin Trials. 2023;134;107352
/ 2023
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
Área: Gastroenterology / Hepatology
Patología: MASLD/MASH
